Europe Poultry Vaccines Market
The Europe Poultry Vaccines Market size was valued at US$ 321.82 Mn in 2023 and is projected to reach US$ 635.01 Mn by 2031, growing at a CAGR of 8.9% during 2023 - 2031.
Report Coverage
- Type: Broiler, Layer
- Technology: Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines)?Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines, Dust/Powdered Vaccines
- Route Of Administration: Drinking water, Intramuscular, Subcutaneous
- End User: Poultry Farms, Veterinary Hospitals, Poultry Vaccination Centers and Clinics
US$ 321.82 Mn
Market size in 2023
US$ 635.01 Mn
Market Size by 2031
8.9%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Poultry Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Poultry Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Poultry Vaccines Market Regional Analysis
6.2 Europe Poultry Vaccines Market Revenue 2021-2031 (US$ Million)
6.3 Europe Poultry Vaccines Market Forecast Analysis
7. Europe Poultry Vaccines Market Analysis – by Type
7.1 Broiler
- 7.1.1 Overview
- 7.1.2 Broiler: Europe Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Layer
- 7.2.1 Overview
- 7.2.2 Layer: Europe Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Europe Poultry Vaccines Market Analysis – by Technology
8.1 Live Attenuated Vaccines
- 8.1.1 Overview
- 8.1.2 Live Attenuated Vaccines: Europe Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Inactivated Vaccines
- 8.2.1 Overview
- 8.2.2 Inactivated Vaccines: Europe Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Recombinant Vaccines?Dosage Form
- 8.3.1 Overview
- 8.3.2 Recombinant Vaccines?Dosage Form : Europe Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Europe Poultry Vaccines Market Analysis – by Route Of Administration
9.1 Drinking water
- 9.1.1 Overview
- 9.1.2 Drinking water: Europe Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Intramuscular
- 9.2.1 Overview
- 9.2.2 Intramuscular: Europe Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Subcutaneous
- 9.3.1 Overview
- 9.3.2 Subcutaneous: Europe Poultry Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Europe Poultry Vaccines Market – Europe Analysis
10.1 Overview
10.2 Europe- 10.2.1 Europe Poultry Vaccines Market Breakdown, by Key Country, 2024 and 2031 (%)
- 10.2.1.1 Europe Poultry Vaccines Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 UK: Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 UK: Europe Poultry Vaccines Market Breakdown, by Type
- 10.2.1.1.2 UK: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.2.1.1.3 UK: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
- 10.2.1.2 Germany: Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Germany: Europe Poultry Vaccines Market Breakdown, by Type
- 10.2.1.2.2 Germany: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.2.1.2.3 Germany: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
- 10.2.1.3 France: Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 France: Europe Poultry Vaccines Market Breakdown, by Type
- 10.2.1.3.2 France: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.2.1.3.3 France: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
- 10.2.1.4 Russia: Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Russia: Europe Poultry Vaccines Market Breakdown, by Type
- 10.2.1.4.2 Russia: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.2.1.4.3 Russia: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
- 10.2.1.5 Italy: Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.5.1 Italy: Europe Poultry Vaccines Market Breakdown, by Type
- 10.2.1.5.2 Italy: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.2.1.5.3 Italy: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
- 10.2.1.6 Rest of Europe: Europe Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Poultry Vaccines Market Breakdown, by Type
- 10.2.1.6.2 Rest of Europe: Europe Poultry Vaccines Market Breakdown, by Technology
- 10.2.1.6.3 Rest of Europe: Europe Poultry Vaccines Market Breakdown, by Route Of Administration
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Boehringer Ingelheim International GmbH.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Zoetis Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Phibro Animal Health Corp.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Dechra Pharmaceuticals PLC.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Elanco Animal Health Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Merck KGaA.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Ceva.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Vaccinova AB.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.